FDA Adverse Event Malfunction Summary report: N

TALENT AAA

MDR report key: 3698742 · Received March 25, 2014

Report

Report Number
2953200-2014-00587
Event Type
Malfunction
Date Received
March 25, 2014
Date of Event
January 1, 2013
Report Date
March 7, 2014
Manufacturer
MEDTRONIC CARDIOVASCULAR
Product Code
MIH
PMA / PMN Number
P070027
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

THE FOLLOWING INFORMATION WAS OBTAINED FROM A JOURNAL ARTICLE. VASCULAR ENDOSTAPLING SYSTEMS FOR VASCULAR ENDOGRAFTS (T)EVAR-SYSTEMATIC REVIEW-CURRENT STATE BAIL, D., WALKER, T., GIEHL, J. VASCULAR AND ENDOVASCULAR SURGERY 2013 47(4) 261-266 DOI: 10.1177/1538574413478474 ABSTRACT PURPOSE: RECENTLY, VASCULAR ENDOSTAPLING SYSTEMS WERE DEVELOPED TO ACHIEVE BETTER SEALING AT THE PROXIMAL NECK OF THE ANEURYSM AND TO PREVENT ENDOGRAFT MIGRATION. THE PURPOSE OF THIS STUDY WAS TO PROVIDE A SYSTEMATIC REVIEW ABOUT THE CURRENT STATE AND POSSIBLE OPTIONS OF VASCULAR ENDOSTAPLING SYSTEMS. RESULTS: NO RANDOMIZED CONTROLLED TRIALS WERE PUBLISHED. THE RESULTS SHOWED THAT THE USE OF AN ENDOSTAPLE SYSTEM CONSIDERABLY REDUCED THE RATES OF ENDOLEAKS TYPE 1A AND ENDOGRAFT MIGRATION. REGARDING THE USE OF ENDOSTAPLES IN DIFFERENT TYPES OF ENDOGRAFTS, ONLY A FEW RESULTS WERE AVAILABLE. CONCLUSION: THE RESULTS ARE NOT CONCLUSIVE. WITH ENDOSTAPLE SYSTEMS, PATIENTS WITH DIFFICULT ANATOMIC FEATURES AND HIGH RISK CAN POTENTIALLY BE TREATED. THESE SYSTEMS MIGHT REDUCE THE HIGH REINTERVENTION RATES AFTER ENDOVASCULAR ANEURYSM REPAIR. CONTROLLED RANDOMIZED TRIALS WITH LARGER NUMBER OF PATIENTS ARE WARRANTED WITH ENDOSTAPLING USE IN PRIMARY ENDOGRAFT IMPLANTATION AND FOR USE IN REINTERVENTION FOR LATE ENDOLEAKS OR ENDOGRAFT MIGRATIONS. THE FOLLOWING EVENTS WERE REPORTED: STENT GRAFT MIGRATION, ENDOLEAK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
175181 TALENT AAA SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH MEDTRONIC CARDIOVASCULAR

Patients

Seq Age Sex Outcome Treatment
1